SARS-CoV-2 Spike P681H Antilichaam [7C11H11] (Omicron, Alpha Variant)

N501YP681H

43740568

P0DTC2

QHD43416

Virus

PM-9375

7C11H11

Unconjugated

Primary Antibodies

Infectious Disease, COVID-19

SARS-CoV-2 (COVID-19) Alpha Variant (B.1.1.7, UK) Spike P681H Antibody is affinity chromatography purified via peptide column.

1 mg/mL

Predicted reactivity based on immunogen sequence: SARS-CoV Spike proteins: (25%)

SARS-CoV-2 (COVID-19) P681H Mutant Specific Spike antibody is supplied in PBS containing 0.02% sodium azide.

None

Blue Ice

SARS-CoV-2 (COVID-19) P681H Mutant Specific Spike antibody can be stored at 4˚ C for three months and -20˚ C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.

IgG2b, Kappa

May cross-react with several virus of interest (VOI) variant lineages that contains P681H mutation, including B.11.318, B.1.621, B.1.621.1, P.3. But all of these lineages are rarely present in current pandemic.

S

Surface glycoprotein

Severe acute respiratory syndrome coronavirus 2

Duchene et al. Virus Evolution 6 (2) : veaa061.

Gu et al. Science 369 (6511) :1603-1607

Hoffmann et al. Molecular Cell 78 (4) :779-784.e5

Davies et al. Science 372 (6538) :eabg3055.

Davies et al. Nature. 593 (7858) :270-274.

Graham, et al. The Lancet Public Health. 6 (5) : e335-e345.

Horby et al. New & Emerging Threats Advisory Group. 2020;91:264-266.

SARS-CoV-2 (COVID-19) P681H Mutant Specific Spike antibody: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Surface Glycoprotein, Spike protein

ELISA, WB

1791269090

Liquid